Geoffrey O'Neill
Corporate Officer/Principal chez The Trustees of Columbia University in The City of New York
Profil
Geoffrey O'Neill is a Professor at both The Trustees of Columbia University in The City of New York and Cornell University.
He was previously the President of Frezer, Inc. from 2005 to 2007, and also served as President of Bio-Matrix Scientific Group, Inc. and BMXP Holdings, Inc.
Postes actifs de Geoffrey O'Neill
| Sociétés | Poste | Début |
|---|---|---|
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - |
Anciens postes connus de Geoffrey O'Neill
| Sociétés | Poste | Fin |
|---|---|---|
| BMXP Holdings, Inc. | President | 11/06/2008 |
Frezer, Inc.
 Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | President | 22/02/2007 |
| Bio-Matrix Scientific Group, Inc. /Old/ | President | 28/08/2006 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Frezer, Inc.
Frezer, Inc. Medical SpecialtiesHealth Technology The Company's principal activity is to develop medical devices. The Company develops Cryogenic Stem Cell Banks. Stem cell banking provides the patient the necessary building blocks for future regenerative medical treatments. Regenerative Medicine helps in finding treatments for diabetes, Parkinson's disease and other degenerative diseases. The Company is in development stage. | Health Technology |
| Bio-Matrix Scientific Group, Inc. /Old/ | Health Technology |
| BMXP Holdings, Inc. | Health Technology |
